PDIA3P1 and esophageal cancer: In our next study, more effective and stable approaches should be applied, such as LNA-based antisense oligonucleotide strategy to target lncRNAs or develop LNPs to encapsulate the si-RNAs, which lead to clinical translational applications of PDIA3P1 as an emerging target against CSCs in esophageal cancer.